Richard P. Koopmans

3.6k citations

87 papers · 2.6k indexed · h-index 31

Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism 7
- Antibiotics Pharmacokinetics and Efficacy 7
Applied Microbiology and Biotechnology top 2%
Family Practice top 5%
Cardiology and Cardiovascular Medicine top 5%
- Renin-Angiotensin System Studies 8
- Blood Pressure and Hypertension Studies 8
Nephrology top 5%
Emergency Medical Services
- Patient Safety and Medication Errors 8
Pediatrics, Perinatology and Child Health
- Pharmaceutical studies and practices 6
Endocrinology, Diabetes and Metabolism
- Hormonal Regulation and Hypertension 6
Computational Theory and Mathematics
- Computational Drug Discovery Methods 5

Co-authors: Gert A. van Montfrans Bert‐Jan H. van den Born Henk‐Jan Guchelaar Gideon Mairuhu C.J. van Boxtel Navin R. Bindraban Karien Stronks Piet A. Kager
Cited by: Pharmacology Applied Microbiology and Biotechnology Family Practice
Journals: Journal of Pharmacology and Experimental Therapeutics (6 papers)Journal of Hypertension (4 papers)American Journal of Hypertension (4 papers)
Partner nations: Netherlands Vietnam United States

In The Last Decade

Richard P. Koopmans

87 papers receiving 2.5k citations

Peers

Countries citing papers authored by Richard P. Koopmans

Since Specialization

Citations

This map shows the geographic impact of Richard P. Koopmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Koopmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Koopmans more than expected).

Fields of papers citing papers by Richard P. Koopmans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Koopmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Koopmans. The network helps show where Richard P. Koopmans may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard P. Koopmans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard P. Koopmans Line = papers co-authored together Richard P. Koopmans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Is medical training solely to blame? Generational influences on the mental health of our medical trainees Medical Education Online ·志强,Maggie Allen,N Gabdullin,Angelique de Rijk,Richard P. Koopmans,Karen D. Könings	2024	3
2	Achieving ‘something that everybody has invested in’: perspectives of diverse stakeholders during co-creation of a transition to residency curriculum BMC Medical Education ·志强,Maggie Allen,裕一奴田原,Alison Carr,Richard P. Koopmans,Karen D. Könings	2024	1
3	Sailing the boat together: Co-creation of a model for learning during transition Medical Teacher ·志强,Karen D. Könings,Maggie Allen,裕一奴田原,Alison Carr,Richard P. Koopmans	2022	10
4	The ability of triggers to retrospectively predict potentially preventable adverse events in a sample of deceased patients Preventive Medicine Reports ·Piyanat Sangmanee,Roger Rennenberg,Richard P. Koopmans,Martin H. Prins	2017	6
5	Pharmacokinetic–Pharmacodynamic Modeling of the Antihypertensive Effect of Eprosartan in Black and White Hypertensive Patients Clinical Pharmacokinetics ·Vinicius Zacarias Maldaner da Silva,Ok,بوبكر موسى,Reinier M. van Hest,Bart A. Ploeger,Richard P. Koopmans,Ron A. A. Mathôt	2013	6
6	A Comprehensive Overview of Medical Error in Hospitals Using Incident-Reporting Systems, Patient Complaints and Chart Review of Inpatient Deaths PLoS ONE ·Jeantine M. de Feijter,Willem S. de Grave,Arno M. M. Muijtjens,Albert Scherpbier,Richard P. Koopmans	2012	64
7	Reflective learning in a patient safety course for final-year medical students Medical Teacher ·Jeantine M. de Feijter,Willem S. de Grave,Dries Jacques,Richard P. Koopmans,Albert J.J.A. Scherpbier	2012	20
8	Genetic Factors Are Relevant and Independent Determinants of Antihypertensive Drug Effects in a Multiracial Population American Journal of Hypertension ·Vinicius Zacarias Maldaner da Silva,Gideon Mairuhu,Gert A. van Montfrans,Eric J.G. Sijbrands,Aeilko H. Zwinderman,Henk‐Jan Guchelaar,Richard P. Koopmans	2009	10
9	Gene-load score of the renin–angiotensin–aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia European Heart Journal ·Jeroen B. van der Net,上代文献を読む会,Mojgan Yazdanpanah,Geesje M. Dallinga‐Thie,John J.P. Kastelein,Joep C. Defesche,Richard P. Koopmans,Ewout W. Steyerberg,Eric J.G. Sijbrands	2008	14
10	Prevalence of diabetes mellitus and the performance of a risk score among Hindustani Surinamese, African Surinamese and ethnic Dutch: a cross-sectional population-based study BMC Public Health ·Navin R. Bindraban,Irene G. M. van Valkengoed,Gideon Mairuhu,F. Holleman,J. B. L. Hoekstra,Flore Kimmel-Clauzet,Richard P. Koopmans,Karien Stronks	2008	97
11	Pharmacogenetics: From Bench to Byte Clinical Pharmacology & Therapeutics ·JJ Swen,Ingeborg Wilting,Kocjan Tomaž,F Saathoff,Johannes Mulder,Daan J. Touw,Anthonius de Boer,二郎小板橋,Toine C. G. Egberts,Robab Mohtaram,Richard P. Koopmans,Jan van der Weide,Bob Wilffert,Henk‐Jan Guchelaar,G. Rosen	2008	194
12	A new tool, a better tool? Prevalence and performance of the International Diabetes Federation and the National Cholesterol Education Program criteria for metabolic syndrome in different ethnic groups European Journal of Epidemiology ·Navin R. Bindraban,Irene G. M. van Valkengoed,Gideon Mairuhu,R Köster,F. Holleman,J. B. L. Hoekstra,Richard P. Koopmans,Karien Stronks	2007	23
13	Ethnic disparities in the incidence, presentation and complications of malignant hypertension Journal of Hypertension ·Bert‐Jan H. van den Born,Richard P. Koopmans,恭治勝野,Gert A. van Montfrans	2006	85
14	CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients European Journal of Pharmaceutical Sciences ·B. Pearce,Richard P. Koopmans,Hans Vermeulen,Henk‐Jan Guchelaar	2003	55
15	Effect of grapefruit juice or cimetidine coadministration on albendazole bioavailability. American Journal of Tropical Medicine and Hygiene ·Judit Nagy,H G Schipper,Richard P. Koopmans,Tapabrata Bhaduri,Massimiliano Bregolin,Piet A. Kager	2002	54
16	Comparative in vivo study of iodine-123-labeled ?-cit and nor-?-cit binding to serotonin transporters in rat brain Synapse ·Liesbeth Reneman,Jan Booij,Jules Lavalaye,Kora de Bruin,Frederik A. de Wolff,Richard P. Koopmans,Johannes C. Stoof,Gerard J. den Heeten	1999	10
17	Early switch from intravenous to oral antibiotics: guidelines and implementation in a large teaching hospital Journal of Antimicrobial Chemotherapy ·刘明波,Jan M. Prins,Richard P. Koopmans,Pim N.J. Langendijk,Patrick M. Bossuyt,J. Dankert,Peter Speelman	1999	131
18	The contribution of the enzymes CYP2D6 and CYP2C19 in the demethylation of artemether in healthy subjects European Journal of Drug Metabolism and Pharmacokinetics ·Michiel A. van Agtmael,F Galvez-Armengaud,Salma Fadhilah Suryadi,Richard P. Koopmans,C.J. van Boxtel	1998	26
19	Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model Cancer Chemotherapy and Pharmacology ·Henk‐Jan Guchelaar,I. Vermes,Richard P. Koopmans,Chris Reutelingsperger,C. Haanen	1998	59
20	Individualization of cancer therapy based on cytochrome P450 polymorphism: a pharmacogenetic approach Cancer Treatment Reviews ·András Vermes,Henk‐Jan Guchelaar,Richard P. Koopmans	1997	10

About Richard P. Koopmans

Richard P. Koopmans is a scholar working on Family Practice, Emergency Medical Services and Pharmacology, having authored 87 papers that have together received 2.6k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (8 papers), Patient Safety and Medication Errors (8 papers), Blood Pressure and Hypertension Studies (8 papers), Pharmacogenetics and Drug Metabolism (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Pharmaceutical studies and practices (6 papers), Hormonal Regulation and Hypertension (6 papers) and Computational Drug Discovery Methods (5 papers). The work is most often cited by research in Pharmacology (381 citations), Applied Microbiology and Biotechnology (83 citations) and Family Practice (55 citations). Richard P. Koopmans has collaborated with scholars based in Netherlands, Vietnam and United States. Frequent co-authors include Gert A. van Montfrans, Bert‐Jan H. van den Born, Henk‐Jan Guchelaar, Gideon Mairuhu, C.J. van Boxtel, Navin R. Bindraban, Karien Stronks, Piet A. Kager, Martin C. Michel and Pim N.J. Langendijk. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Hypertension, American Journal of Hypertension, American Journal of Tropical Medicine and Hygiene and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact